s. Symptoms of peritonitis may includecloudy peritoneal effluent, pain, erythema or drainage at the exit site, or fever.
Because patients self-administer EXTRANEAL at home, patients should also be instructed to:Bring their EXTRANEAL Patient Kit with them when receiving care outside of the dialysis clinic toinform health care providers of their EXTRANEAL use so that only glucose-specific monitors and teststrips are used. An EXTRANEAL Patient Kit will be shipped to the patient’s home once EXTRANEAL isadded to their prescription, following training by the dialysis clinic.
Follow the peritoneal dialysis (PD) training instructions given by the health care provider. Use aseptictechnique throughout their entire PD procedure. Discard any unused EXTRANEAL solution [see Dosageand Administration (2.2)].
Check the appearance of EXTRANEAL solution prior to use. Do not use EXTRANEAL if solution appears
cloudy, discolored, contain visible particulate matter, or if there is evidence of leaking containers.
Regularly check fluid balance and body weight to avoid over-hydration or dehydration and associated side
effects.
Inform their physicians about any changes in prescription or over-the-counter medications and
supplements.
Have periodic laboratory tests and routinely follow up with their health care provider.
In case of damage, the container should be discarded.
Baxter, Ambu-Flex, Extraneal, MiniCap and UltraBag (or Ultrabag) are trademarks of Baxter International Inc.
Baxter Healthcare Corporation
Deerfield, IL 60015 USA
Printed in USA
http://baxterpi.com/pi-pdf/Extraneal_PI.pdf
|
